Notes / Company

Gennex Laboratories Ltd.

GENNEX BSE 531739 ISIN INE509C01026 Pharmaceuticals

Fundamentals

Market cap: ₹251 cr
P/E: 11.97×
ROE: 9.71%
Debt / equity: 0.13
52-week range: 7.05 — 17.25

The timeline — 1 note on Gennex Laboratories Ltd.

June 2026

10 Jun 26 · 4:29 PM IST Lead

Lead · Credit · Micro cap

Gennex promoter's pledge ratio jumps to 24% on a small loan

A ₹1.25 crore loan pushed Premier Fiscal's pledged stock to 12.5 million shares. The company's market cap is just ₹256 crore.

Verify on exchange BSE filings for GENNEX NSE filings for GENNEX